Genbi Maisie (02161.HK) plans to spin off Baojiyuan and list it separately on the Main Board of the Hong Kong Stock Exchange.

Wisdom Financial APP News, Genexine (02161.HK) announced that the company proposes to spin off the group's branded Chinese medicine products and Chinese medicine clinic services business on the main board of the Hong Kong Stock Exchange, with a global offering of shares. The independent listing of Genexine will constitute the company's spin-off of Genexine in accordance with Application Guidance 15.